← SearchCellular Prion Protein Targeting Monoclonal Antibody Antagonist as a Therapy for Alzheimer's Disease$449,995R44FY2020AGNIHAllyx Biosciences, Inc., New Haven CTInvestigatorsTimothy R SiegertcontactView original record on NIH RePORTER →